Wikidata

(Q64396351)

English

A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of t

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

title
An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention (English)
0 references
medical condition
Atrial Fibrillation
0 references
syndrome
0 references
country
Argentina
0 references
Australia
0 references
Austria
0 references
Belgium
0 references
Brazil
0 references
Bulgaria
0 references
Canada
0 references
Chile
0 references
Colombia
0 references
Croatia
0 references
Denmark
0 references
France
0 references
Germany
0 references
Hungary
0 references
India
0 references
Israel
0 references
Italy
0 references
Mexico
0 references
Netherlands
0 references
Norway
0 references
Peru
0 references
Poland
0 references
Portugal
0 references
Romania
0 references
Serbia
0 references
Slovakia
0 references
Spain
0 references
Sweden
0 references
Switzerland
0 references
Ukraine
0 references
United Kingdom
0 references
start time
4 June 2015
0 references
end time
10 November 2018
0 references
number of participants
4,614
0 references
minimum age
18 year
0 references
maximum age
95 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64396351&oldid=2235556150"